• Journal of Pharmaceutical Investigation
• /
• 제19권4호
• /
• pp.185-190
• /
• 1989

The release of angiotensin and ${\alpha}-amylase$ from monolithic devices of different molecular weight of polyethylene glycol (PEC) grafted polyurethane copolymer was investigated. Water-soluble PEG grafted polymer provided a controlled release of angiotensin and ${\alpha}-amylase$. The release rate of angiotensin and ${\alpha}-amylase$ could be controlled by varying the molecular weight of PEC grafted. The release mechanism may be associated with the creation of pore or domain through the devices following the gel swelling and self-aggregation by PEC grafted polymer. Hydrophobic polyurethane grafted with PEG can provide a biomaterial for prolonged release of angiotensin and ${\alpha}-amylase$ from angiotensin and ${\alpha}-amylase$ blended system.

• Macromolecular Research
• /
• 제14권1호
• /
• pp.73-80
• /
• 2006

Sulfonated poly(ethylene glycol) (PEG-$SO_{3}$) grafted polyrotaxanes (PRx-PEG-$SO_{3}$) were prepared in order to utilize the unique properties of PEG-$SO_{3}$ and the supramolecular structure of PRx, in which PEG-$SO_{3}$ grafted $\alpha$-cyclodextrins ($\alpha$-CDs) were threaded onto PEG segments in a PEG-b-poly(propylene glycol) (PPG)-b-PEG triblock copolymer (Pluronic) chain capped with bulky end groups. Some of the PRx-PEG-$SO_{3}$ demonstrated a higher anticoagulant activity in case of PRx-PEG-$SO_{3}$ (P 105), and compared with the control they showed a lower fibrinogen adsorption in PRx-PEG-$SO_{3}$ (F68) and a higher binding affinity with fibroblast growth factor. The obtained results suggested that polyrotaxane incorporated with PEG-$SO_{3}$ may be applicable to the surface modification of clinically used polymers, especially for blood/cell compatible medical devices.

• Journal of Pharmaceutical Investigation
• /
• 제21권3호
• /
• pp.143-147
• /
• 1991

${\alpha}-amylase$ was immobilized on the surface of polyethylene glycol(M.W. 2000) grafted polyurethane film using diisocyanate in an attemp to develop enzyme immobilized polymeric materials. The surface morphology of the modified polyurethane film was examined by SEM. Effects of pH and temperature on the activity of the immobilized ${\alpha}-amylase$ were investigated. The optimal pH range of the activity was $7.0{\sim}7.5.$ The immobilized ${\alpha}-amylase$ demonstrated high thermal stability and maintained consistent activity during long-term storage.

• Macromolecular Research
• /
• 제17권7호
• /
• pp.458-463
• /
• 2009

Polyurethane (PU) is widely used as a cardiovascular biomaterial due to its good mechanical properties and hemocompatibility, but it is not adhesive to endothelial cells (ECs). Cell adhesive peptides, GRGDS and YIGSR, were found to promote adhesion and spreading of ECs and showed a synergistic effect when both of them were used. In this study, a surface modification was designed to fabricate an EC-active PU surface capable of promoting endothelialization using the peptides and poly(ethylene glycol) (PEG) spacer, The modified PU surfaces were characterized in vitro. The density of the grafted PEG on the PU surface was measured by acid-base back titration to the terminal-free isocyanate groups. The successful immobilization of pep tides was confirmed by amino acid analysis, following hydrolysis, and contact angle measurement. The uniform distribution of peptides on the surface was observed by scanning electron microscopy (SEM) and atomic force microscopy (AFM). To evaluate the EC adhesive property, cell viability test using human umbilical vein EC (HUVEC) was investigated in vitro and enhanced endothelialization was characterized by the introduction of cell adhesive peptides, GRGDS and YIGSR, and PEG spacer. Therefore, GRGDS and YIGSR co-immobilized PU surfaces can be applied to an EC-specific vascular graft with long-term patency by endothelialization.

• Macromolecular Research
• /
• 제12권5호
• /
• pp.512-518
• /
• 2004

We have synthesized a novel macromonomer of vinyl-terminated bifunctional polyurethane having a molecular weight of 37,000 g/mol and successfully applied it to the dispersion polymerization of methylmethacrylate(MMA). We verified the presence of the vinyl terminal group and the macromonomer grafted onto the poly(ethylene glycol)(PEG) block in the PMMA particles by using $^1$H and $\^$13/C NMR spectroscopies. Monodisperse PMMA microspheres that have good uniformity of 1.01 were prepared at 20 wt% macromonomer content; we investigated the characteristics of the PMMA particles in terms of their molecular weight, molecular weight distribution, size of the particles, thermal properties, and glass transition temperature. We have found that the synthesized polyurethane macromonomer is an effective stabilizer.

• 한국고분자학회:학술대회논문집
• /
• 한국고분자학회 2006년도 IUPAC International Symposium on Advanced Polymers for Emerging Technologies
• /
• pp.86-88
• /
• 2006

The novel linear- (V-LUM) and cross-type macromonomers (C-VUM) of vinyl-terminated bifunctional polyurethane were synthesized and applied to the dispersion polymerization of styrene and MMA in ethanol. The existence of the vinyl terminal groups and the grafted macromonomer with styrene and PMMA was verified using 1H NMR and 13C NMR. Monodisperse polystyrene (PS) microspheres were successfully obtained above 15 wt % of macromonomer relative to styrene. The macromonomer can efficiently stabilize higher surface area of the particles compared to a conventional stabilizer, PVP. The grafting ratio of the PS calculated from 1H NMR linearly increased up to 0.048 with 20 wt % of the macromonomer and the high molecular weights (501,300 g/mol) of PS with increased glass transition and enhanced thermal stability were obtained. Furthermore, the stable and monodisperse PMMA microspheres having a weight-average diameter of $5.09{\mu}m$ and a good uniformity of 1.01 were obtained with 20 wt% L-VUM. The molecular weight increased, but the size of the PMMA particles decreased with the macromonomer concentration due to the increased stabilizing effect. The molecular weight of the PMMA was approximately two fold higher than that by a conventional PVP. The L-VUM acts as a reactive stabilizer, which gives polyurethane-grafted PS or PMMA with a high molecular weight. In addition, the XPS result showed that the C-PS (PS using the C-VUM) was anchored with a larger amount of PEG than that of the L-PS (PS using the L-VUM) on the particle surface. Thus, the reaction and stabilizing mechanism of the macromonomers for the formation of PS particles is proposed.

• 폴리머
• /
• 제33권6호
• /
• pp.602-607
• /
• 2009

심혈관용 소재로서 혈관내피전구세포의 포획을 통해 in vivo 내피세포화가 가능한 표면을 가진 폴리우레탄 표면을 개발하였다. 혈관내피전구세포의 점착을 유도하는 CD34 단일클론항체(monoclonal antibody, mAb)를 표면에 도입하기 위해, poly (poly (ethylene glycol) acrylate-co-butyl methacrylate), poly (PEGA-co-BMA) 공중합체가 합성되었고, 이를 폴리우레탄 표면에 코팅하여 CD34 단일클론항체를 화학적으로 고정화하였다. 중합된 공중합체의 $^1H$-NMR 분석은 원하는 조성을 가진 poly(PEGA-co-BMA)의 합성이 가능함을 확인해 주었다. 이전 연구에서 개발된 PEG가 그래프트된 폴리우레탄과의 비교를 통해, 본 연구에서 제조된 poly(PEGA-co-BMA)가 코팅된 폴리우레탄 표면이 CD34 mAb의 고정화에 더 효과적인 것으로 나타났으며, 이는 CD34 mAb의 표면밀도와 활성도가 32배 이상 증가된 결과를 통해 증명되었다. 개질된 폴리우레탄 표면의 물리화학적 특성은 XPS와 물 접촉각, AFM에 의해 분석되었으며, 각각의 개질된 표면에 따른 표면의 특이적 성질을 잘 보여주었다. 본 연구에서 얻어진 결과들은 poly(PEGA-co-BMA)의 코팅을 통해 제조된 표면이 CD34 mAb의 고정화에 효과적임을 설명하였으며, 실제로 심혈관용 소재의 개발에 적용 가능성이 크다는 것을 증명해 주었다.